Health Catalyst Inc
NASDAQ:HCAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Health Catalyst Inc
NASDAQ:HCAT
|
US |
|
S
|
Shanghai Fudan Forward S&T Co Ltd
SSE:600624
|
CN |
|
F
|
Formetal Co Ltd
KOSDAQ:119500
|
KR |
|
M
|
Mycron Steel Bhd
KLSE:MYCRON
|
MY |
|
S
|
Spur Corporation Ltd
XBER:S2J
|
ZA |
Wall Street
Price Targets
HCAT Price Targets Summary
Health Catalyst Inc
According to Wall Street analysts, the average 1-year price target for
HCAT
is 2.14 USD
with a low forecast of 1.01 USD and a high forecast of 3.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HCAT's stock price target?
Price Target
2.14
USD
According to Wall Street analysts, the average 1-year price target for
HCAT
is 2.14 USD
with a low forecast of 1.01 USD and a high forecast of 3.15 USD.
What is Health Catalyst Inc's Revenue forecast?
Projected CAGR
1%
For the last 7 years the
compound annual growth rate for
Health Catalyst Inc's revenue is
16%.
The projected
CAGR
for the next 3 years is
1%.